Product References
Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes.
International journal of molecular sciences
Tritto V,Capitanio D,Gelfi C,Riva P
36-0700 was used in Western Blotting to suggest that the presence of one subclinical variant can activate the RAS pathway below the pathological threshold, which can instead be exceeded by the additive effect due to the co-presence of two subclinical variants causing NS, supporting our digenic inheritance hypothesis.
Fri Feb 17 00:00:00 EST 2023
Changes of RAS Pathway Phosphorylation in Lymphoblastoid Cell Lines from Noonan Syndrome Patients Carrying Hypomorphic Variants in Two NS Genes.
International journal of molecular sciences
Tritto V,Capitanio D,Gelfi C,Riva P
36-0700 was used in Western Blotting to suggest that the presence of one subclinical variant can activate the RAS pathway below the pathological threshold, which can instead be exceeded by the additive effect due to the co-presence of two subclinical variants causing NS, supporting our digenic inheritance hypothesis.
Fri Feb 17 00:00:00 EST 2023
Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition.
Science advances
Wu Y,Chen K,Xing G,Li L,Ma B,Hu Z,Duan L,Liu X
36-0700 was used in Immunocytochemistry-immunoflourescence to reveal dynamic changes in phospholipids occurring during reprogramming and show that the CDP-ethanolamine (CDP-Etn) pathway for phosphatidylethanolamine (PE) synthesis is required at the early stage of reprogramming.
Fri Nov 01 00:00:00 EDT 2019
Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition.
Science advances
Wu Y,Chen K,Xing G,Li L,Ma B,Hu Z,Duan L,Liu X
36-0700 was used in Immunocytochemistry-immunoflourescence to reveal dynamic changes in phospholipids occurring during reprogramming and show that the CDP-ethanolamine (CDP-Etn) pathway for phosphatidylethanolamine (PE) synthesis is required at the early stage of reprogramming.
Fri Nov 01 00:00:00 EDT 2019
Phospholipid remodeling is critical for stem cell pluripotency by facilitating mesenchymal-to-epithelial transition.
Science advances
Wu Y,Chen K,Xing G,Li L,Ma B,Hu Z,Duan L,Liu X
36-0700 was used in Immunocytochemistry-immunoflourescence to reveal dynamic changes in phospholipids occurring during reprogramming and show that the CDP-ethanolamine (CDP-Etn) pathway for phosphatidylethanolamine (PE) synthesis is required at the early stage of reprogramming.
Fri Nov 01 00:00:00 EDT 2019
Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene-targeted mice.
The EMBO journal
Kanellopoulos AH,Koenig J,Huang H,Pyrski M,Millet Q,Lolignier S,Morohashi T,Gossage SJ,Jay M,Linley JE,Baskozos G,Kessler BM,Cox JJ,Dolphin AC,Zufall F,Wood JN,Zhao J
Published figure using PEBP1 polyclonal antibody (Product # 36-0700) in Western Blot
Thu Feb 01 00:00:00 EST 2018
Mapping protein interactions of sodium channel NaV1.7 using epitope-tagged gene-targeted mice.
The EMBO journal
Kanellopoulos AH,Koenig J,Huang H,Pyrski M,Millet Q,Lolignier S,Morohashi T,Gossage SJ,Jay M,Linley JE,Baskozos G,Kessler BM,Cox JJ,Dolphin AC,Zufall F,Wood JN,Zhao J
Published figure using PEBP1 polyclonal antibody (Product # 36-0700) in Western Blot
Thu Feb 01 00:00:00 EST 2018
Effects of Raf kinase inhibitor protein expression on pancreatic cancer cell growth and motility: an in vivo and in vitro study.
Journal of cancer research and clinical oncology
Dai H,Chen H,Liu W,You Y,Tan J,Yang A,Lai X,Bie P
360700 was used in immunohistochemistry - paraffin section to evaluate the effects of Raf kinase inhibitor protein on pancreatic carcinoma cells
Sat Oct 01 00:00:00 EDT 2016
Polycomb protein EZH2 regulates tumor invasion via the transcriptional repression of the metastasis suppressor RKIP in breast and prostate cancer.
Cancer research
Ren G,Baritaki S,Marathe H,Feng J,Park S,Beach S,Bazeley PS,Beshir AB,Fenteany G,Mehra R,Daignault S,Al-Mulla F,Keller E,Bonavida B,de la Serna I,Yeung KC
36-0700 was used in immunohistochemistry and western blot to investigate the role of polycomb protein EZH2 in tumor invasion
Fri Jun 15 00:00:00 EDT 2012
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Journal of cellular biochemistry
Mc Henry KT,Montesano R,Zhu S,Beshir AB,Tang HH,Yeung KC,Fenteany G
Fri Feb 15 00:00:00 EST 2008
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Journal of cellular biochemistry
Mc Henry KT,Montesano R,Zhu S,Beshir AB,Tang HH,Yeung KC,Fenteany G
Fri Feb 15 00:00:00 EST 2008
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Journal of cellular biochemistry
Mc Henry KT,Montesano R,Zhu S,Beshir AB,Tang HH,Yeung KC,Fenteany G
Fri Feb 15 00:00:00 EST 2008
Raf kinase inhibitor protein positively regulates cell-substratum adhesion while negatively regulating cell-cell adhesion.
Journal of cellular biochemistry
Mc Henry KT,Montesano R,Zhu S,Beshir AB,Tang HH,Yeung KC,Fenteany G
Fri Feb 15 00:00:00 EST 2008
Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Cancer research
Jazirehi AR,Huerta-Yepez S,Cheng G,Bonavida B
Sat Jan 01 00:00:00 EST 2005
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Cancer research
Jazirehi AR,Vega MI,Chatterjee D,Goodglick L,Bonavida B
Fri Oct 01 00:00:00 EDT 2004
Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Cancer research
Jazirehi AR,Vega MI,Chatterjee D,Goodglick L,Bonavida B
Fri Oct 01 00:00:00 EDT 2004